| Supplement Facts
Serving Size: 1 Capsule |
|||
|
Amount Per Serving |
%DV* | % Daily Value for Pregnant or Lactating Women |
|
| Vitamin C (as Sodium Ascorbate) | 75 mg | 83% | 63% |
| Vitamin B1 (as Thiamine Hydrochloride) | 2 mg | 167% | 143% |
| Vitamin B2 (Riboflavin) | 3 mg | 231% | 188% |
| Vitamin B3 (as Niacinamide) | 10 mg | 63% | 56% |
| Vitamin B6 (Pyridoxine HCl) | 10 mg | 588% | 500% |
| Folic Acid | 1.25 mg | 313% | 208% |
| Vitamin B12 (Cyanocobalamin) | 12 mcg | 500% | 429% |
| Biotin | 300 mcg | 1000% | 857% |
| Pantothenic Acid (as Calcium D-Pantothenate) | 6 mg | 120% | 86% |
| Iron (65 mg from Ferrous Fumarate) (65 mg from Polysaccharide Iron Complex) | 130 mg | 722% | 481% |
| Lactobacillus casei (KE-99) 200 Billion CFU/g** | 30 mg | † | † |
| * % Daily Values are based on a 2,000 calorie intake of adults and children 12 years and older. † Daily value not established **Colony Forming Units (CFU) per gram at time of manufacturing |
|||
Other Ingredients: Titanium Dioxide, Candurin Silver Fine, Carmine, Magnesium Stearate, Microcrystalline Cellulose and Hypromellose.
Patent Numbers: USA:6,797,266;5,626,883;Mexico MX/a/2008/004461; Singapore: 200802623-9 and other countries.
INDICATIONS: Fusion PlusTM is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. Also for treatment of condition in which iron deficiency and vitamin C deficiency occur together, along with a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence.
CONTRAINDICATIONS: Fusion PlusTM is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. It is also contraindicated in patients suffering from pernicious anemia as folic acid may obscure its signs and symptoms.
Ferrous Fumarate and Polysaccharide Iron Complex: All FusionTM products include a unique patented source of iron, e.g. Ferrous Fumarate and Polysaccharide Iron Complex (U.S. Patent No: 11/243,043 Pending). An increase in tolerability is observed with the (patented formulation) and is believed to occur as the result of distributing the total iron content in the composition among compounds that provide iron to the patients blood stream via two different mechanisms. The ferrous salts are readily absorbed in the upper gut, by direct dissolution and absorption of the ferrous iron by the bloodstream. However, the iron available from PIC is absorbed in the lower gut, via an active protein transport mechanism.
Clinical Studies: Picinni, L.-Ricciotti, M. 1982. Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemias: PANMINERVA MEDICA-EUROPA MEDICA, Vol. 24, No.3. pp.213-220 (July-September 1982).
Folic Acid: Folic Acid is one of the important hematopoietic agents necessary for proper regeneration of the blood-forming elements and their function. Additionally, folic acid increases jejunal glycolytic enzymes and is involved in the desaturation and hydroxylation of long-chain fatty acids in the brain. A deficiency in folic acid results in megaloblastic anemia.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. |
WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient.
PRECAUTIONS: Folic acid in doses above 0.1 mg – 0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive. The use of this product by immunocompromised patients or treatment of any disorder must be medically supervised by a physician.
DOSAGE AND ADMINISTRATION: Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.
HOW SUPPLIED: Fusion PlusTM are pearl red opaque Vcaps® capsules printed in white with “US” Logo on the cap and “FPlus” on the body. Packed in child resistant cap and light resistant bottle of 30 capsules (52747-0502-30). The listed product number is not a National Drug Code. Instead, US Pharmaceutical Corporation has assigned this product code formatted according to the standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
Iron / Folic Acid / Vitamin / Probiotic Supplement Capsules
Consult package literature for full prescription information. You should contact your healthcare provider for medical advice about adverse events. To report a serious adverse event, contact US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036. Marketed by US Pharmaceutical Corporation. Manufactured with Vcaps® Plus capsule shells. Store at room temperature 15° to 30°C (59° to 86°F) and dry place.
Manufactured in a FDA registered facility in the USA.
